🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sangamo Therapeutics, Inc. (SGMOQ)
OTCMKTS · Delayed Price · Currency is USD
0.1060
-0.0021 (-1.94%)
At close: Nov 20, 2026

Sangamo Therapeutics Revenue

Sangamo Therapeutics had revenue of $1.44M in the quarter ending March 31, 2026, a decrease of -77.60%. This brings the company's total for the last twelve months to $34.56M, down -45.80% year-over-year. In the year 2025, Sangamo Therapeutics had annual revenue of $39.55M, down -31.57%. That makes Sangamo Therapeutics the 30,532nd largest company in the world by revenue and 4,022nd in the United States.

Revenue (ttm)
34.56M
Revenue Growth
-45.80%
P/S Ratio
1.27
Revenue / Employee
243.36K
Employees
142
Market Cap
43.91M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202539.55M-18.25M-31.57%
Dec 31, 202457.80M-118.43M-67.20%
Dec 31, 2023176.23M64.93M58.34%
Dec 31, 2022111.30M598.00K0.54%
Dec 31, 2021110.70M-7.49M-6.34%
Dec 31, 2020118.19M15.76M15.39%
Dec 31, 2019102.43M17.98M21.29%
Dec 31, 201884.45M47.89M130.95%
Dec 31, 201736.57M17.18M88.60%
Dec 31, 201619.39M-20.15M-50.96%
Dec 31, 201539.54M-6.33M-13.80%
Dec 31, 201445.87M21.74M90.07%
Dec 31, 201324.13M2.48M11.44%
Dec 31, 201221.66M11.34M109.86%
Dec 31, 201110.32M-10.49M-50.40%
Dec 31, 201020.81M-1.38M-6.23%
Dec 31, 200922.19M6.00M37.08%
Dec 31, 200816.19M7.09M77.91%
Dec 31, 20079.10M1.21M15.38%
Dec 31, 20067.89M5.40M217.43%
Dec 31, 20052.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Vaxart181.27M
Nuo Therapeutics6.03M
ZIVO Bioscience209.03K
Arch Biopartners113.25K
Provectus Biopharmaceuticals57.48K
Revenue Rankings